Edition:
United States

BioDelivery Sciences International Inc (BDSI.OQ)

BDSI.OQ on NASDAQ Stock Exchange Capital Market

2.83USD
1:30pm EDT
Change (% chg)

$0.05 (+1.80%)
Prev Close
$2.78
Open
$2.80
Day's High
$2.85
Day's Low
$2.80
Volume
8,410
Avg. Vol
54,916
52-wk High
$3.60
52-wk Low
$1.70

Select another date:

Tue, May 22 2018

BRIEF-BioDelivery Sciences Announces Closing Of $50 Mln Equity Financing; Appointment Of Peter Greenleaf As Chairman

* BIODELIVERY SCIENCES ANNOUNCES CLOSING OF $50 MILLION EQUITY FINANCING AND APPOINTMENT OF PETER GREENLEAF AS CHAIRMAN OF THE BOARD Source text for Eikon: Further company coverage:

BRIEF-BioDelivery Sciences Announces Agreement With Broadfin Capital On Comprehensive Plan To Strengthen Business

* BIODELIVERY SCIENCES ANNOUNCES AGREEMENT WITH BROADFIN CAPITAL ON COMPREHENSIVE PLAN TO STRENGTHEN BUSINESS

BRIEF-Biodelivery Sciences Reports Q1 Loss Per Share $0.18

* BIODELIVERY SCIENCES REPORTS POSITIVE FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-BioDelivery Sciences Appoints Herm Cukier As CEO

* BIODELIVERY SCIENCES APPOINTS HERM CUKIER AS CHIEF EXECUTIVE OFFICER

BRIEF-Broadfin Says Delivered Letter To BioDelivery Sciences With Nominations For Board

* BROADFIN - ON APRIL 27, DELIVERED LETTER TO BIODELIVERY SCIENCES NOMINATING TODD C. DAVIS, PETER S. GREENLEAF, STEPHEN T. WILLS FOR ELECTION TO BOARD

BRIEF-Broadfin Capital Reports 7.3 Pct Stake In Biodelivery Sciences

April 10 BioDelivery Sciences International Inc :

BRIEF-Biodelivery Sciences Reports Q4 Loss Per Share $0.29

March 15 Biodelivery Sciences International Inc :

BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva

* BIODELIVERY SCIENCES ANNOUNCES BELBUCA PATENT LITIGATION SETTLEMENT AGREEMENT WITH TEVA

BRIEF-BioDelivery Sciences Announces Launch And Availability Of Belbuca In Canada

* BIODELIVERY SCIENCES ANNOUNCES LAUNCH AND AVAILABILITY OF BELBUCA® IN CANADA Source text for Eikon: Further company coverage:

Select another date: